“…This is in contrast to the previous experience that EHDP is a potent inhibitor of mineralisation in several models of experimental calcification. Thus EHDP inhibits mineralisation of growth cartilage and metaphyseal osteoid in rats (Schenk et al, 1973) in cutaneous (Casey et al, 1972) and cardiac (Rosenblum, Black and Ferrell, 1973) calciphylaxis, in calcergy induced by potassium permanganate (KMnO,) in the rat (Doyle, Dunn and Willoughby, 1979) and calcergy induced by lead acetate (PbAc) in the mouse (McClure, 1979).…”